The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Investigation

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI118460PMID 8609218PMCID PMC507099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

  1995cited by this paper
• Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study.

  1995cited by this paper
• Liver glycogen turnover in fed and fasted humans.

  1994influential reference
• 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.

  1994influential reference
• Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

  1993cited by this paper
• Radioactive and Stable Isotope Tracers in Biomedicine

  1993cited by this paper
• Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging

  1992cited by this paper
• Pathways of glycogen repletion.

  1992cited by this paper
• Sources of carbon for hepatic glycogen synthesis in the conscious dog.

  1991cited by this paper
• Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

  1991cited by this paper
• Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

  1990cited by this paper
• Quantitative comparison of pathways of hepatic glycogen repletion in fed and fasted humans.

  1990cited by this paper
• Metabolic Effects of Long-Acting Somatostatin Analogue (Sandostatin) in Type I Diabetic Patients on Conventional Therapy

  1989cited by this paper
• The effects of SMS 201-995 (sandostatin) on metabolic profiles in insulin-dependent diabetes mellitus.

  1989cited by this paper
• Testing of the assumptions made in estimating the extent of futile cycling.

  1989cited by this paper
• Similar Dose Responsiveness of Hepatic Glycogenolysis and Gluconeogenesis to Glucagon In Vivo

  1987cited by this paper
• Somatostatin analogue SMS 201-995 in type I diabetes mellitus. Initial experience after repeated administration.

  1986cited by this paper
• Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas.

  1986cited by this paper
• Reduced Postprandial Hyperglycemia After Subcutaneous Injection of a Somatostatin-Analogue (SMS 201-995) in Insulin-dependent Diabetes Mellitus

  1985cited by this paper
• Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver.

  1984cited by this paper
• A microfluorometric method for the determination of free fatty acids in plasma.

  1983cited by this paper
• Control of gluconeogenesis in rat liver cells. I. Kinetics of the individual enzymes and the effect of glucagon.

  1983cited by this paper
• Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.

  1983cited by this paper
• Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

  1983cited by this paper
• Control of gluconeogenesis in rat liver cells

  1983cited by this paper
• Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

  1982cited by this paper
• Dose-response characteristics for effects of insulin on production and utilization of glucose in man.

  1981cited by this paper
• Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

  1980cited by this paper
• Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man

  1979cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.

  1979cited by this paper
• Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.

  1978cited by this paper
• 24-Hour Studies of the Effects of Somatostatin on the Levels of Plasma Growth Hormone, Glucagon, and Glucose in Normal Subjects and Juvenile Diabetics

  1978cited by this paper
• Effect of Insulin Therapy on the Profiles of Plasma Immunoreactive Glucagon in Juvenile-type and Adult-type Diabetics

  1978cited by this paper
• The control of glycogen metabolism in the liver.

  1976cited by this paper
• Stimulation of hepatic glycogen synthesis by amino acids.

  1976cited by this paper
• Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.

  1976cited by this paper
• The essential role of glucagon in the pathogenesis of diabetes mellitus.

  1975cited by this paper
• Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

  1975cited by this paper
• Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.

  1975cited by this paper
• Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.

  1975cited by this paper
• Gluconeogenesis from Alanine in Normal Postabsorptive Man: Intrahepatic Stimulatory Effect of Glucagon

  1975cited by this paper
• Liver and muscle glycogen in man after glucose and fructose infusion.

  1974cited by this paper
• Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

  1974cited by this paper
• Glycogen synthesis in the perfused liver of the starved rat.

  1971cited by this paper
• Portal and Peripheral Vein Immunoreactive Insulin Concentrations Before and After Glucose Infusion

  1970cited by this paper
• Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats.

  1967cited by this paper

• Protein Nutrition for Endurance Athletes: A Metabolic Focus on Promoting Recovery and Training Adaptation

  2025cites this paper
• Co-ingesting whey protein with dual-source carbohydrate enhances amino acid availability without compromising post-exercise liver glycogen resynthesis.

  2025cites this paper
• Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance

  2025cites this paper
• Comparison of the Effect of Intermittent Fasting with Mediterranean Diet on Glycemic, Lipid, and Anthropometric Indices in Type 2 Diabetes: A Review of Randomized Controlled Trials.

  2025cites this paper
• Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway

  2025cites this paper
• Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives.

  2024cites this paper
• Interleaved trinuclear MRS for single‐session investigation of carbohydrate and lipid metabolism in human liver at 7T

  2024cites this paper
• MRI of GlycoNOE in the human liver using GraspNOE‐Dixon

  2024cites this paper
• Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial

  2022cites this paper
• Catestatin induces glycogenesis by stimulating the phosphoinositide 3‐kinase‐AKT pathway

  2022cites this paper
• Ketone monoester ingestion increases post-exercise serum erythropoietin concentrations in healthy men.

  2022cites this paper
• Carb-conscious: the role of carbohydrate intake in recovery from exercise

  2021cites this paper
• Dietary palmitate and oleate differently modulate insulin sensitivity in human skeletal muscle

  2021cites this paper
• Exercise, CaMKII, and type 2 diabetes

  2021cites this paper
• Childhood diabetes and sleep

  2021cites this paper
• Treatment of type 2 diabetes in children: what are the specific considerations?

  2021cites this paper
• Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.

  2020cites this paper
• NAFLD and Insulin Resistance: A Multisystemic Disease

  2020cites this paper
• Non‐alcoholic Fatty Liver Disease and Insulin Resistance

  2020cites this paper
• Catestatin induces glycogenesis by stimulating phosphoinositide 3-kinase-AKT pathway

  2020cites this paper
• Other types of diffuse liver disease: is there a way to do it?

  2020cites this paper
• Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study

  2020cites this paper
• The effects of glucose-fructose co-ingestion on repeated performance during a day of intensified rugby union training in professional academy players

  2020cites this paper
• Glycogen structure in type 1 diabetic mice: Towards understanding the origin of diabetic glycogen molecular fragility.

  2019cites this paper
• Role of Mitochondria in the Liver Metabolism in Obesity and Type 2 Diabetes

  2019cites this paper
• Application of Magnetic Resonance Spectroscopy in metabolic research.

  2019cites this paper
• Metabolic effects of glucagon in humans

  2018cites this paper
• Mechanisms of Insulin Action and Insulin Resistance.

  2018cites this paper
• Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts

  2018cites this paper
• Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study

  2018cites this paper
• Metabolic mechanisms behind the type 2 diabetes susceptible phenotype in low birth weight individuals

  2018cites this paper
• Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes.

  2018cites this paper
• Interorgan Metabolic Crosstalk in Human Insulin Resistance.

  2018cites this paper
• Associations Between Variants in the NF- κB1 Gene, Alone or in Combination with Saturated Fats, and Anthropometric Traits in Young Adults

  2017cites this paper
• Insulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages

  2017cites this paper
• 13C MRS Studies of the Control of Hepatic Glycogen Metabolism at High Magnetic Fields

  2017cites this paper
• Evaluation of hepatic glycogen content, some haematological and biochemical parameters of alloxan-induced diabetic rats treated with combinations of glibenclamide and G. latifolium extract

  2017cites this paper
• Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance

  2017cites this paper
• The effect of characteristics of proteins fed during gestation and lactation on development of metabolic syndrome in dams and male offspring of Wistar rats

  2017cites this paper
• Editorial: In Vivo Magnetic Resonance at Ultra High Field

  2017cites this paper
• Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice

  2017cites this paper
• Microbial regulation of Insulin-like peptide 5 and its implication on metabolism and bariatric surgery

  2016cites this paper
• 13C MRS in Human Tissue

  2016cites this paper
• Liver glycogen metabolism during and after prolonged endurance-type 1 exercise 2

  2016cites this paper
• Transcriptomic Changes in Liver of Young Bulls Caused by Diets Low in Mineral and Protein Contents and Supplemented with n-3 Fatty Acids and Conjugated Linoleic Acid

  2016cites this paper
• Liver glycogen metabolism during and after prolonged endurance-type exercise.

  2016influential citation
• The Role of Circulating Amino Acids in the Hypothalamic Regulation of Liver Glucose Metabolism.

  2016cites this paper
• Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes.

  2016cites this paper
• Plasma amino acid levels are elevated in young, healthy low birth weight men exposed to short‐term high‐fat overfeeding

  2016cites this paper
• Regulation of Liver Glucose Metabolism by the Metabolic Sensing of Leucine in the Hypothalamus

  2015cites this paper
• Insulin:Carbohydrate Ratio—Part of the Story

  2015cites this paper
• Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity

  2015cites this paper
• Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases

  2015cites this paper
• Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans

  2015cites this paper
• The effect of fermentable carbohydrate on glucose homeostasis and weight management in people at high-risk of developing diabetes

  2014cites this paper
• Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial

  2014cites this paper
• Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice

  2014cites this paper
• Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

  2014cites this paper
• Glucagon-Like Peptide-1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Diabetes

  2014cites this paper
• The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

  2014cites this paper
• Acquired copper imbalance in diabetes-induced cardiac disease: Molecular mechanisms and reversibility

  2013cites this paper
• Liver and muscle glycogen repletion using 13C magnetic resonance spectroscopy following ingestion of maltodextrin, galactose, protein and amino acids.

  2013cites this paper
• Mechanisms Underlying the Onset of Oral Lipid–Induced Skeletal Muscle Insulin Resistance in Humans

  2013cites this paper
• Noninvasive Fluxomics in Mammals by Nuclear Magnetic Resonance Spectroscopy

  2012cites this paper
• Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus

  2012cites this paper
• Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

  2012cites this paper
• Peroxisome Proliferator-Activated Receptor β/δ (PPAR β/δ) as a Potential Therapeutic Target for Dyslipidemia

  2012cites this paper
• The Handbook of Metabolomics

  2012cites this paper
• Postprandial and Fasting Hepatic Glucose Fluxes in Long-Standing Type 1 Diabetes

  2011cites this paper
• Profiling the control of hepatic glucose and lipid metabolism for evaluating novel strategies of insulin delivery

  2011cites this paper
• Dietary Proteins as Determinants of Metabolic and Physiologic Functions of the Gastrointestinal Tract

  2011cites this paper
• Effects of two commercially available feline diets on glucose and insulin concentrations, insulin sensitivity and energetic efficiency of weight gain.

  2011cites this paper
• Metabolic syndrome as a risk factor for neurological disorders

  2011cites this paper
• Efecte de l'activació de PPARβ/δ sobre l'oxidació d'àcids grassos i el procés inflamatori

  2011cites this paper
• Hypothalamic Leucine Metabolism Regulates Liver Glucose Production

  2011cites this paper
• ACCIONES LIPOSTÁTICAS DE LA LEPTINA ACTUANDO VÍA SISTEMA NERVIOSO CENTRAL: MECANISMOS MOLECULARES EN EL HÍGADO Y EN EL TEJIDO ADIPOSO

  2011cites this paper
• Identification des éléments clefs du métabolisme des lipides et de leurs régulateurs

  2010cites this paper
• Effect of a short sprint on glucose production and whole body glucose utilisation in adults with Type 1 diabetes

  2010cites this paper
• Serum Osteoprotegerin, a Potential Novel Marker of Systemic Inflammation: The Influence of Obesity, Insulin Sensitivity and Oral Glucose Loading on its Circulating Concentrations

  2010cites this paper
• Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities

  2010cites this paper
• Quantitative proteomic analysis of S-nitrosated proteins in diabetic mouse liver with ICAT switch method

  2010cites this paper
• The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease

  2010cites this paper
• Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes

  2009cites this paper
• The 6th Annual World Congress on the Insulin Resistance Syndrome

  2009cites this paper
• Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin

  2009cites this paper
• The Use of Magnetic Resonance Methods in Translational Cardiovascular Research

  2009cites this paper
• The Role of Fatty Acids on Toll-like Receptor 4 Regulation of Substrate Metabolism with Obesity

  2009cites this paper
• The impact of obesity, sex, and diet on hepatic glucose production in cats.

  2009cites this paper
• Beyond insulin replacement: addressing the additional needs of the diabetes patient

  2008cites this paper
• Hepatic glucose production and insulin resistance

  2008cites this paper
• Disordered lipid metabolism and the pathogenesis of insulin resistance.

  2007cites this paper
• The metabolic changes caused by dexamethasone in the adjuvant-induced arthritic rat

  2007cites this paper
• Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study

  2007cites this paper
• Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.

  2007cites this paper
• Third Annual World Congress on the Insulin Resistance Syndrome

  2006cites this paper
• MR in Clinical Diabetes Research and Drug Trials

  2006cites this paper
• Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

  2006cites this paper
• Changes in hepatic glycogen cycling during a glucose load in healthy humans

  2006cites this paper
• Chronic hepatitis C and diabetes mellitus.

  2006cites this paper
• Effects of dietary protein on glucose homeostasis

  2006cites this paper